NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-131-2000-0-CA-04 Methods for Reducing Tumor Growth and Metastasis by Inhibiting MCP-1 Activity CA National Stage 2409298 Abandoned
NCI E-136-1998-0-US-10 Novel Thiolesters and Uses Thereof US National Stage 09/701,451 6706729 Abandoned PDF
NCI E-002-2001-0-US-01 tumor Antigen Homologous To Poly (A) Polymerase US 60/291,668 Abandoned
NCI E-134-2000-0-PCT-02 Utilization of Non-Viral Sequences For Minus-Strand DNA Transfer and Gene Reconstitution PCT PCT PCT/US2001/015739 Abandoned
NCI E-194-1989-0-US-06 RNA PROBE FOR DETECTING C-FES MRNA US CON 09/859,000 Abandoned
NCI E-265-1994-1-US-03 NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE, INT6, US CON 09/858,152 6737251 Abandoned PDF
NICHD E-224-2001-0-US-01 Modified Leptin (as filed) US 60/290,722 Abandoned
NICHD E-184-2001-0-US-01 Modified Growth Hormone (as filed) US 60/290,836 Abandoned
NIMH E-174-2000-0-US-01 Effect of COMT Genotype on Frontal Lobe Function US 60/290,565 Abandoned
NIDCR E-177-1996-0-US-04 SERUM-FREE CELL GROWTH MEDIUM US CON 09/851,921 6617161 Abandoned PDF
NIDCR E-171-1996-0-US-03 TARGETING ANTIGENS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN US DIV 09/853,530 Abandoned
NINDS E-234-2000-0-US-01 A PCR Based Technique For Diagnosis of The Major Mutation Mucolipidosis IV US ORD 09/851,494 7041448 Expired PDF
NIDDK E-165-1999-0-PCT-02 Potentiation of Antineoplastic Agents Using Sigma-2 Ligands PCT PCT PCT/US01/40688 Expired
NIAID E-304-1998-0-US-01 Recombinant proteins of t he swine hepatitis E virus and their uses as a vaccine and diagnostic reagents for medical and veterinary applns. US 60/289,220 Abandoned
NCI E-075-2000-0-EP-04 NITRIC OXIDE-RELEASING METALLIC MEDICAL DEVICE EP National Stage 01932992.9 Expired
NCI E-075-2000-0-GB-09 NITRIC OXIDE Releasing Metallic Medical Devices GB EP 01932992.9 Abandoned
NCI E-075-2000-0-DE-07 NITRIC OXIDE Releasing Metallic Medical Devices DE EP 01932992.9 Abandoned
NCI E-075-2000-0-FR-08 NITRIC OXIDE Releasing Metallic Medical Devices FR EP 01932992.9 Abandoned
NCI E-075-2000-0-IE-10 NITRIC OXIDE Releasing Metallic Medical Devices IE EP 01932992.9 Abandoned
NIDDK E-253-1999-1-US-03 Methods for Reducing Intraocular Pressure US ORD 09/743,744 6528516 Expired PDF
NCI E-075-2000-0-PCT-02 Nitric Oxide-Releasing Metallic Medical Devices PCT PCT PCT/US01/014407 Expired
NIAID E-187-1995-2-US-02 Method For Producing Self-Replicating Infectious RSV Particules Comprising Recombinant RSV Genomes or Antigenomes And The N,P,L, ...3 US DIV 09/847,173 6790449 Expired PDF
NIDCD E-217-2001-0-US-01 Intranasal Immunization With Detoxified Lipooligosaccharide From Moraxella Catarrhalis or Nontypeable Haemophilus Influenzae or With... US 60/288,695 Abandoned
NHLBI E-250-2001-0-US-03 Regulatory Nucleic Acid For The ABC1 Gene, Molecules Modifying Its Activity And Therapeutics Uses US ORD 09/846,456 7378274 Expired PDF
NIAAA E-041-2000-0-US-02 METHODS of And Compounds For Inhibiting Calpains US National Stage 09/847,872 6448245 Abandoned PDF
NIAAA E-041-2000-0-PCT-03 METHODS FOR INHIBITING CALPAIN PCT PCT PCT/US01/40652 Expired
NHLBI E-250-2001-0-PCT-02 Regulatory Nucleic Acid For The ABC1 Gene, Molecules Modifying Its Activity And Therapeutics Uses PCT PCT PCT/EP01/005488 Expired
NCI E-223-1998-0-US-03 p53 VEGF Regulate Tumor Growth of NOS2 Expressing Cancer Cells US National Stage 09/830,977 Abandoned
NICHD E-293-1998-0-US-03 Cloning and Characterization of Two M-RNA Transcription Factors US National Stage 09/830,942 Abandoned
NCI E-216-2001-0-US-01 Soybean Leachate: Plant Inhibitor And Potential Cancer therapeutic US 60/288,309 Abandoned
NINDS E-291-1999-0-PCT-02 DERIVATION OF MIDBRAIN DOPPAMINERGIC NEURONS FROM EMBRYONIC STEM CELLS PCT PCT PCT/US01/14051 Expired
NCI E-179-2001-0-US-01 Identification of a Cell Surface Receptor For Papillomaviruses US 60/287,776 Abandoned
NCI E-157-2000-0-AU-05 Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines AU National Stage 2001259291 Expired
NCI E-259-1998-2-US-06 Variants of Humanized Anti-Carcinoma MAB CC49 US National Stage 09/830,748 6818749 Expired PDF
NCI E-157-2000-0-PCT-02 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines PCT PCT PCT/US2001/013968 Expired
NCI E-157-2000-0-EP-04 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines EP National Stage 01932792.3 Abandoned
NCI E-157-2000-0-CA-06 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines CA National Stage 2407303 Abandoned
NCI E-157-2000-0-JP-07 Improved Immunogenicity Using a Combination of DNA And Vaccinia Virus Vector Vaccines JP National Stage 2001-579837 Abandoned
NICHD E-163-2000-0-US-02 Use of Cumulative Distribution Functions to Determine Protein Purity And Homogeneity. US ORD 09/844,962 Abandoned
NCI E-215-1994-0-US-08 METHOD OF PRODUCING SINGLE-CHAIN FV MOLECULES US CON 09/844,650 Abandoned
NIA E-175-2001-0-US-01 Method And Structures For Microengineering Neocartilage Scaffolds US 60/286,852 Abandoned
NHLBI E-301-2000-0-US-01 Protein From Group B Streptococcus Responsible For Pulmonary Hypertension in Neonates, And Methods of Use Thereof US 60/287,235 Abandoned
NCI E-285-2003-0-US-01 A Method For Integrating Laser Capture Microdissection With Layered Expression Scanning US 60/286,258 Abandoned
NINDS E-206-2000-1-US-01 Mehtods of Increasing Distribution of Nucleic Acids US 60/286,308 Abandoned
NCI E-302-2000-1-US-01 Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas US 60/285,690 Abandoned
NCI E-187-2001-0-US-03 Structure Determination of Material Using Electron Microscopy US National Stage 10/475,821 6987266 Abandoned PDF
NCI E-187-2001-0-US-01 Structure Determination of Material Using Electron Microscopy US 60/285,819 Abandoned
NIAID E-096-2000-0-PCT-02 INDUCIBLE PLASMID VECTOR ENCODING TGF-beta AND USES THEREOF PCT PCT PCT/US01/12980 Abandoned
NCI E-087-1996-0-US-05 HETEROLOGOUS BOOSTING IMMUNIZATIONS US CON 09/838,987 Abandoned
NCI E-190-1998-0-US-07 Water-Soluble Drugs and Methods for Their Production US National Stage 09/743,873 6747055 Abandoned PDF